描述类范围内的黄类生物活性,同时最大限度地减少化合物特异性效应,使用等分混合战略
Alex Xiong Gao1,2, Amy Xiao-Yang Wang1,2, Zheng-Qi Wang1,2
1Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong 999077, China.
Journal of agricultural and food chemistry
|October 23, 2025
概括
一种充当类参考的黄化合物混合物显示了保留的神经营养活性,缓冲了特定的毒性作用. 这种方法有助于绘制营养和药理学中的黄类功能.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 黄类化合物具有共同的C6-C3-C6核心,但在侧链结构上有所不同.
- 黄胺结构的变化会影响它们的生物活动和潜在的毒性.
- 对于营养和药理学应用来说,了解全类和特定的黄类效应至关重要.
研究的目的:
- 评价一个等等级跨子类的黄化合物混合物作为"类参考",以捕获广泛的生物活性.
- 确定混合物是否可以稀释异常效应,例如特定毒性或相互作用.
- 建立一个框架,在各种情况下绘制类素功能.
主要方法:
- 准备了一种来自五个子类的20种黄类的等分质混合物.
- 这种混合物和五种代表性的单一黄素在老鼠PC12细胞中进行了测试.
- 试验包括NGF诱导的神经元分化,记者基因激活 (神经纤维,cAMP,NF-κB,抗氧化剂反应),细胞毒性,线粒体脱极化和粉样β结合.
主要成果:
- 黄化合物混合物增强了NGF诱导的神经元分化,并激活了关键的细胞反应通路,类似于单一代表.
- 所有测试的黄类药物在5μM时是无毒的,但在50μM时是有毒的,纳林根因是例外.
- 这种混合物减轻了氨酸诱导的线粒体脱极化和细胞毒性.
- 与EGCG相比,该混合物对粉样蛋白-β(1-42) 的结合明显较弱,这表明特定相互作用的稀释.
结论:
- 一种等等的黄化合物混合物可以作为一个类参考,反映保存的神经营养活动.
- 混合物可以缓冲特定的异常效应,如毒性和强烈的个人相互作用.
- 这种概念验证为研究黄类功能提供了有价值的框架和工具.
更多相关视频
相关概念视频
01:22Bioavailability: Influencing Factors
334
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
334
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
293
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
293
01:20Measurement of Bioavailability: Pharmacodynamic Methods
230
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
230
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
232
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
232
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
177
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
177
01:23Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K